Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Cerebrovascular Disorders » Intracranial Hemorrhages » Cerebral Hemorrhage
Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Cerebrovascular Disorders » Intracranial Hemorrhages » Cerebral Hemorrhage
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Hemorrhage » Intracranial Hemorrhages » Cerebral Hemorrhage
Description
Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA. MeSH
Hierarchy View
Subtype Terms (3)
Basal Ganglia Hemorrhage
1 experimental drug
Cerebral Intraventricular Hemorrhage
25 drugs (21 approved, 4 experimental)
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (21)
Phase 2 Indicated Drugs (23)
Other Experimental Indicated Drugs (18)
Organization Involved with Phase 4 Indications (14)
Organization Involved with Phase 3 Indications (55)
Basildon and Thurrock University Hospitals NHS Foundation Trust
East Kent Hospitals University NHS Foundation Trust
Institut National de la Santé Et de la Recherche Médicale, France
Medical University of South Carolina
Mid Yorkshire Hospitals NHS Trust
National Cerebral and Cardiovascular Center
National Institute of Neurological Disorders and Stroke (NINDS)
Organization Involved with Phase 2 Indications (77)
Alberta Heritage Foundation for Medical Research
Beijing Fangshan District Liangxiang Hospital
Canadian Institutes of Health Research (CIHR)
Case Western Reserve University
China Academy of Chinese Medical Sciences
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
International Neuroscience Institute Hanover
National Center for Research Resources (NCRR)
National Institute for Health Research, United Kingdom
National Institutes of Health (NIH)
National Neuroscience Institute
Salford Royal Foundation NHS Trust
Sunnybrook Health Sciences Centre
The Florey Institute of Neuroscience and Mental Health
Universidad Autonoma de San Luis Potosi
University of California, Los Angeles
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (16)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.